Secreted stromal protein ISLR promotes intestinal regeneration by suppressing epithelial Hippo signaling.
Jiuzhi XuYang TangXiaole ShengYuhua TianMin DengSujuan DuCong LvGuili LiYuwei PanYongli SongPengbo LouYongting LuoYuan LiBing ZhangYanmei ChenZhanju LiuYingzi CongMaksim V PlikusQingyong MengZhaocai ZhouZhengquan YuPublished in: The EMBO journal (2020)
The Hippo-YAP signaling pathway plays an essential role in epithelial cells during intestinal regeneration and tumorigenesis. However, the molecular mechanism linking stromal signals to YAP-mediated intestinal regeneration and tumorigenesis is poorly defined. Here, we report a stroma-epithelium ISLR-YAP signaling axis essential for stromal cells to modulate epithelial cell growth during intestinal regeneration and tumorigenesis. Specifically, upon inflammation and in cancer, an oncogenic transcription factor ETS1 in stromal cells induces expression of a secreted protein ISLR that can inhibit Hippo signaling and activate YAP in epithelial cells. Deletion of Islr in stromal cells in mice markedly impaired intestinal regeneration and suppressed tumorigenesis in the colon. Moreover, the expression of stromal cell-specific ISLR and ETS1 significantly increased in inflamed mucosa of human IBD patients and in human colorectal adenocarcinoma, accounting for the epithelial YAP hyperactivation. Collectively, our findings provide new insights into the signaling crosstalk between stroma and epithelium during tissue regeneration and tumorigenesis.
Keyphrases
- stem cells
- transcription factor
- endothelial cells
- bone marrow
- signaling pathway
- poor prognosis
- wound healing
- binding protein
- cell therapy
- squamous cell carcinoma
- ejection fraction
- single cell
- type diabetes
- adipose tissue
- prognostic factors
- metabolic syndrome
- epithelial mesenchymal transition
- radiation therapy
- papillary thyroid
- cell proliferation
- small molecule
- insulin resistance
- patient reported
- rectal cancer
- genome wide identification
- ulcerative colitis